Latest News

Thursday, May 21, 2015 | Clinical Trials

Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma

Isarna Therapeutics announced that the European Medicines Agency (EMA) has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, for the prevention of…

Read the full story

Thursday, May 21, 2015 | Medical Studies

Scientists Look at 'The Dress' and Answer the Color Conundrum

Black and blue or white and gold? That is the question that took the world by storm back in February after two friends from Scotland posted a picture of a dress online seeking an answer because they d…

Read the full story

Thursday, May 21, 2015 | Medical Studies

Novel Anticoagulants May Not Boost Intraocular Bleeding Risk

Compared to other antithrombotic drugs, novel oral anticoagulants (NOACs) do not pose an extra risk of substantial intraocular bleeding, according to Portuguese researchers. As Dr. Daniel Caldeira tol…

Read the full story

Thursday, May 21, 2015 | Management/Leadership, GrayBug

GrayBug Announces Leadership Transition

GrayBug announced that Jeffrey L. Cleland, PhD, will assume the role of interim chief executive officer, according to a company news release. Christy Shaffer, PhD, managing director of Hatteras Discov…

Read the full story

Wednesday, May 20, 2015 | Earnings & Financials

ClarVista Medical Completes $14 Million Series B Financing to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, developer of the Harmoni system, a modular and exchangeable IOL for lens replacement after cataract surgery, announced that it has secured $14 million in Series B financing,…

Read the full story

Wednesday, May 20, 2015 | Medical Studies

Risk of Surgeries May Offset Benefit of Intraocular Lens in Infants

A higher risk of multiple surgeries may offset any advantages to implanted intraocular lenses (IoLs) after cataract surgery in infants, a new study has found. "Our findings regarding early outcom…

Read the full story

Wednesday, May 20, 2015 | Medical Studies

Regorafenib Eye Drops Show Promise in Primate AMD Model

Topical eye drops of regorafenib (Bayer HealthCare), a multikinase inhibitor targeting vascular endothelial growth factor 2, were safe and effective when given to monkeys that had laser-induced choroi…

Read the full story

Tuesday, May 19, 2015 | Medical Studies, Alcon Laboratories

Alcon Study Reveals Nearly Half of Americans Would Avoid Reading Glasses If They Knew It Made Them Look Older

According to a new survey conducted by Jacksonville University in Florida, one in four adults say reading glasses can make someone look 10 years older, according to an Alcon news release. The survey, …

Read the full story

Tuesday, May 19, 2015 | Product Releases, Nidek

Nidek Launches HandyRef-K and HandyRef

Nidek announced the launch of the HandyRef-K/HandyRef, a handheld refractometer that is a portable solution for accurate refraction and keratometry measurements, according to a company news rele…

Read the full story

Tuesday, May 19, 2015 | Management/Leadership, Acucela

Acucela Nominates Shintaro Asako to Its Board of Directors

Acucela has announced that it has nominated Shintaro Asako to stand for election to the company’s board of directors at the 2015 annual meeting of shareholders on June 25, 2015 at Acucela’…

Read the full story

Monday, May 18, 2015 | Clinical Trials, Dry Eye, Eleven Biotherapeutics

Eleven Biotherapeutics’ Dry Eye Drug Candidate Fails to Meet Both Primary Endpoints in Phase 3 Trial

Eleven Biotherapeutics announced that its lead dry eye drug candidate, EBI-005, did not meet either of the two coprimary endpoints of the phase 3 OASIS study, the company’s first pivotal phase 3…

Read the full story

Monday, May 18, 2015 | Partnerships, R-Tech Ueno

R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University

R-Tech Ueno has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate School o…

Read the full story

Monday, May 18, 2015 | Clinical Trials, Allegro Ophthalmics

Allegro Ophthalmics Announces Issuance of US Patent for First-in-Class Integrin Peptide Therapy Candidate Luminate

Allegro Ophthalmics announced that the United States Patent and Trademark Office has issued a patent (no. 9,018,352) covering the composition of matter of Allegro’s product candidate, Luminate (…

Read the full story

Monday, May 18, 2015 | Product Releases, Bausch+Lomb

Bausch + Lomb Announces the Availability of its Enhanced Trulign Toric Intraocular Lens Calculator

Bausch + Lomb launched a number of enhancements to its Trulign Toric IOL calculator, which is designed to allow surgeons to successfully select the appropriate IOL power range for cataract patients, a…

Read the full story

Friday, May 15, 2015 | Clinical Trials, Ocular Therapeutix

Ocular Therapeutix Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Postsurgical Ocular Pain Indication

During its first-quarter earnings report, Ocular Therapeutix provided an update on its clinical and preclinical programs for its proprietary hydrogel platform technology. Following a meeting with the …

Read the full story
Load More